首页> 外文期刊>Trials >The EMPOWER-SUSTAIN e-Health Intervention to improve patient activation and self-management behaviours among individuals with Metabolic Syndrome in primary care: study protocol for a pilot randomised controlled trial
【24h】

The EMPOWER-SUSTAIN e-Health Intervention to improve patient activation and self-management behaviours among individuals with Metabolic Syndrome in primary care: study protocol for a pilot randomised controlled trial

机译:在初级保健中提高患者激活和自我管理行为的授权 - 维持电子健康干预:试点随机对照试验的研究议定书

获取原文
           

摘要

Epidemiological studies conducted in various parts of the world have clearly demonstrated that metabolic syndrome (MetS) is an increasing global health problem, not only in Western societies but also in Asian populations. Web-based and mobile phone-based self-management applications have been proven to be effective in improving self-management behaviour of patients with MetS components (i.e., diabetes or hypertension). However, evidence is lacking in terms of their effectiveness specifically for patients with MetS. The aim of this pilot study is to evaluate the feasibility and potential effectiveness of the EMPOWER-SUSTAIN Self-Management e-Health Intervention in improving activation and self-management behaviours among patients with MetS. This paper presents the study protocol. A pilot randomised controlled trial will be conducted in a university primary care clinic. A total of 232 patients aged 18–60?years with MetS will be recruited; 116 will be randomised to receive the EMPOWER-SUSTAIN intervention for 6?months, and another 116 patients will continue with usual care. The EMPOWER-SUSTAIN intervention is a multifaceted chronic disease management strategy based on the Chronic Care Model and persuasive technology theory. It consists of training primary care physicians, nurses and patients to use the EMPOWER-SUSTAIN web-based self-management mobile app, strengthening the patient–physician relationship and reinforcing the use of relevant clinical practice guidelines to guide management and prescribing. The primary outcome is the mean change in patient activation score using the Patient Activation Measure short form Malay version (PAM-13-M) questionnaire. The secondary outcomes include the changes in waist circumference, body mass index, blood pressure, patient physical activity level, eating behaviour, perception of chronic illness care, satisfaction with patient–physician interaction, and perceived absolute 10-year cardiovascular disease risk. Feasibility of implementing the intervention will be evaluated. This includes acceptability of the intervention, estimating the likely rate of participant recruitment and retention, appropriateness of the outcome measures, calculation of sample size, and the intervention’s potential effectiveness. To our knowledge, this is the first study in Malaysia that aims to determine the feasibility of a multifaceted e-health intervention, as well as to indicate more useful aspects of this intervention for further exploration in a larger trial. ClinicalTrials.gov, NCT04120779. Registered on 9 October 2019, protocol version 1.
机译:在世界各地进行的流行病学研究明确表明,代谢综合征(METS)是一项越来越多的全球健康问题,不仅在西方社会中,还在亚洲人口中。已被证明基于网络和基于移动电话的自我管理应用程序在提高Mets组分(即,糖尿病或高血压)的自我管理行为方面是有效的。然而,证据缺乏他们专门针对Mets患者的效果。该试点研究的目的是评估Empower-Resive自我管理电子健康干预的可行性和潜力效力,从而改善Mets患者的激活和自我管理行为。本文提出了研究方案。将在大学初级保健诊所进行飞行员随机对照试验。共有232名18-60岁的患者?将招募与MET的年份; 116将随机化以获得6月6日的授权 - 维持干预,另外116名患者将继续普通护理。授权 - 维持干预是一种基于慢性护理模型和有说服力技术理论的多方面慢性疾病管理战略。它包括培训初级保健医生,护士和患者,利用授权维持基于网络的自我管理移动应用程序,加强患者医生的关系,加强相关临床实践指南的使用来指导管理和处方。主要结果是使用患者激活测量的患者激活分数的平均变化,即马来文版本(PAM-13-M)问卷。二次结果包括腰围,体重指数,血压,患者身体活性水平,饮食行为,对慢性疾病的感知,对患者 - 医师的相互作用的满意度,以及感知到绝对的10年心血管疾病风险。将评估实施干预的可行性。这包括干预的可接受性,估计参与者招募和保留的可能率,结果措施的适当性,样本规模的计算以及介入的潜在效果。为了我们的知识,这是马来西亚的第一次研究,旨在确定多方面的电子健康干预的可行性,以及表明这种干预的更多有用方面,以便在更大的审判中进一步探索。 ClinicalTrials.gov,NCT04120779。 2019年10月9日注册,协议版本1。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号